| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Poisoning by carbamazepine |
Causative agent (attribute) |
True |
Carbamazepine (substance) |
Inferred relationship |
Some |
1 |
| Carbamazepine blood measurement |
Component |
False |
Carbamazepine (substance) |
Inferred relationship |
Some |
2 |
| Serum carbamazepine measurement |
Component |
False |
Carbamazepine (substance) |
Inferred relationship |
Some |
2 |
| Accidental poisoning caused by carbamazepine (disorder) |
Causative agent (attribute) |
False |
Carbamazepine (substance) |
Inferred relationship |
Some |
|
| Intentional poisoning by carbamazepine |
Causative agent (attribute) |
False |
Carbamazepine (substance) |
Inferred relationship |
Some |
|
| Poisoning caused by carbamazepine of undetermined intent |
Causative agent (attribute) |
False |
Carbamazepine (substance) |
Inferred relationship |
Some |
1 |
| Carbamazepine adverse reaction |
Causative agent (attribute) |
True |
Carbamazepine (substance) |
Inferred relationship |
Some |
1 |
| Allergy to carbamazepine (finding) |
Causative agent (attribute) |
False |
Carbamazepine (substance) |
Inferred relationship |
Some |
|
| Overdose of carbamazepine |
Causative agent (attribute) |
True |
Carbamazepine (substance) |
Inferred relationship |
Some |
1 |
| Accidental overdose by carbamazepine |
Causative agent (attribute) |
True |
Carbamazepine (substance) |
Inferred relationship |
Some |
1 |
| Intentional overdose by carbamazepine |
Causative agent (attribute) |
True |
Carbamazepine (substance) |
Inferred relationship |
Some |
1 |
| surdose de carbamazépine d'intention indéterminée |
Causative agent (attribute) |
False |
Carbamazepine (substance) |
Inferred relationship |
Some |
1 |
| Oxcarbazepine (substance) |
Is a |
False |
Carbamazepine (substance) |
Inferred relationship |
Some |
|
| Carbamazepine-10,11-epoxide measurement |
Component |
False |
Carbamazepine (substance) |
Inferred relationship |
Some |
|
| Carbamazepine measurement |
Component |
True |
Carbamazepine (substance) |
Inferred relationship |
Some |
1 |
| Carbamazepine-10,11-epoxide |
Is a |
False |
Carbamazepine (substance) |
Inferred relationship |
Some |
|
| Carbamazepine 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbamazepine (substance) |
Inferred relationship |
Some |
|
| Carbamazepine 200mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbamazepine (substance) |
Inferred relationship |
Some |
|
| Carbamazepine 400mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbamazepine (substance) |
Inferred relationship |
Some |
|
| Carbamazepine 125 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbamazepine (substance) |
Inferred relationship |
Some |
|
| Carbamazepine 250 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbamazepine (substance) |
Inferred relationship |
Some |
|
| Carbamazepine 200 mg chewable tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbamazepine (substance) |
Inferred relationship |
Some |
|
| Product containing precisely carbamazepine 100 milligram/1 each conventional release chewable tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbamazepine (substance) |
Inferred relationship |
Some |
|
| Product containing carbamazepine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Carbamazepine (substance) |
Inferred relationship |
Some |
1 |
| Carbamazepine 100mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbamazepine (substance) |
Inferred relationship |
Some |
|
| Carbamazepine 300mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbamazepine (substance) |
Inferred relationship |
Some |
|
| Carbamazepine 200mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbamazepine (substance) |
Inferred relationship |
Some |
|
| Carbamazepine 100mg/5 mL suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbamazepine (substance) |
Inferred relationship |
Some |
|
| Product containing carbamazepine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Carbamazepine (substance) |
Inferred relationship |
Some |
1 |
| Carbamazepine-containing product in rectal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Carbamazepine (substance) |
Inferred relationship |
Some |
1 |
| Carbamazepine 100mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbamazepine (substance) |
Inferred relationship |
Some |
|
| Oral form carbamazepine m/r |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbamazepine (substance) |
Inferred relationship |
Some |
|
| Plasma carbamazepine level (procedure) |
Component |
False |
Carbamazepine (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely carbamazepine 20 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbamazepine (substance) |
Inferred relationship |
Some |
|
| Carbamazepine 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbamazepine (substance) |
Inferred relationship |
Some |
|
| Carbamazepine 400 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbamazepine (substance) |
Inferred relationship |
Some |
|
| Accidental poisoning caused by carbamazepine (disorder) |
Causative agent (attribute) |
True |
Carbamazepine (substance) |
Inferred relationship |
Some |
1 |
| Intentional poisoning by carbamazepine |
Causative agent (attribute) |
True |
Carbamazepine (substance) |
Inferred relationship |
Some |
1 |
| Measurement of free carbamazepine (procedure) |
Component |
False |
Carbamazepine (substance) |
Inferred relationship |
Some |
1 |
| Allergy to carbamazepine (finding) |
Causative agent (attribute) |
True |
Carbamazepine (substance) |
Inferred relationship |
Some |
1 |
| Carbamazepine 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbamazepine (substance) |
Inferred relationship |
Some |
1 |
| Carbamazepine 100 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Carbamazepine (substance) |
Inferred relationship |
Some |
1 |
| Carbamazepine 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbamazepine (substance) |
Inferred relationship |
Some |
1 |
| Carbamazepine 200 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Carbamazepine (substance) |
Inferred relationship |
Some |
1 |
| Carbamazepine 400 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbamazepine (substance) |
Inferred relationship |
Some |
1 |
| Carbamazepine 400 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Carbamazepine (substance) |
Inferred relationship |
Some |
1 |
| Carbamazepine 100mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbamazepine (substance) |
Inferred relationship |
Some |
|
| Carbamazepine 300mg prolonged-release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbamazepine (substance) |
Inferred relationship |
Some |
|
| Carbamazepine 200mg prolonged-release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbamazepine (substance) |
Inferred relationship |
Some |
|
| Carbamazepine 100mg prolonged-release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbamazepine (substance) |
Inferred relationship |
Some |
|
| Carbamazepine-10,11-epoxide |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Carbamazepine (substance) |
Inferred relationship |
Some |
|
| Product containing precisely carbamazepine 400 milligram/1 each prolonged-release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Carbamazepine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely carbamazepine 400 milligram/1 each prolonged-release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Carbamazepine (substance) |
Inferred relationship |
Some |
1 |
| Carbamazepine 125 mg rectal suppository |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Carbamazepine (substance) |
Inferred relationship |
Some |
1 |
| Carbamazepine 125 mg rectal suppository |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Carbamazepine (substance) |
Inferred relationship |
Some |
1 |
| Carbamazepine 250 mg rectal suppository |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Carbamazepine (substance) |
Inferred relationship |
Some |
1 |
| Carbamazepine 250 mg rectal suppository |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Carbamazepine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely carbamazepine 100 milligram/1 each conventional release chewable tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Carbamazepine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely carbamazepine 100 milligram/1 each conventional release chewable tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Carbamazepine (substance) |
Inferred relationship |
Some |
1 |
| Carbamazepine 200 mg chewable tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Carbamazepine (substance) |
Inferred relationship |
Some |
1 |
| Carbamazepine 200 mg chewable tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Carbamazepine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely carbamazepine 200 milligram/1 each prolonged-release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Carbamazepine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely carbamazepine 200 milligram/1 each prolonged-release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Carbamazepine (substance) |
Inferred relationship |
Some |
1 |
| Carbamazepine 200 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Carbamazepine (substance) |
Inferred relationship |
Some |
1 |
| Carbamazepine 400 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Carbamazepine (substance) |
Inferred relationship |
Some |
1 |
| Carbamazepine 100 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Carbamazepine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely carbamazepine 20 milligram/1 milliliter conventional release oral suspension (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Carbamazepine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely carbamazepine 20 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Carbamazepine (substance) |
Inferred relationship |
Some |
1 |
| Product containing only carbamazepine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Carbamazepine (substance) |
Inferred relationship |
Some |
1 |
| Product containing only carbamazepine in rectal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Carbamazepine (substance) |
Inferred relationship |
Some |
1 |
| Carbamazepine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Carbamazepine (substance) |
Inferred relationship |
Some |
1 |
| Fetal carbamazepine syndrome |
Causative agent (attribute) |
True |
Carbamazepine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely carbamazepine 600 milligram/1 each prolonged-release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Carbamazepine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely carbamazepine 600 milligram/1 each prolonged-release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Carbamazepine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely carbamazepine 150 milligram/1 each prolonged-release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Carbamazepine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely carbamazepine 150 milligram/1 each prolonged-release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Carbamazepine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely carbamazepine 300 milligram/1 each prolonged-release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Carbamazepine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely carbamazepine 300 milligram/1 each prolonged-release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Carbamazepine (substance) |
Inferred relationship |
Some |
1 |
| Carbamazepine blood measurement |
Component |
True |
Carbamazepine (substance) |
Inferred relationship |
Some |
1 |
| Serum carbamazepine measurement |
Component |
True |
Carbamazepine (substance) |
Inferred relationship |
Some |
1 |
| Plasma carbamazepine level (procedure) |
Component |
True |
Carbamazepine (substance) |
Inferred relationship |
Some |
1 |
| Measurement of free carbamazepine (procedure) |
Component |
True |
Carbamazepine (substance) |
Inferred relationship |
Some |
2 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]